biologics Archives - Express Pharma

OneSource Specialty Pharma and Formycon AG announce strategic manufacturing partnership for biosimilars

Powering India’s biologics future: Industry-academia partnerships as the engine of growth

Panel Discussion: Moving up the value chain without losing volume advantage

ICON and CII host dialogue on Indian Pharma’s move toward US manufacturing

Global divide emerges among physicians over patient choice in biologics vs. biosimilars, reveals GlobalData

COPD market to surpass $30.2 billion in 7MM in 2033, driven by biologics and precision medicine, forecasts GlobalData

OX40 inhibitors may transform atopic dermatitis landscape: GlobalData

Syngene concludes acquisition of Emergent BioSolutions’ biologics manufacturing facility

Targeted therapies and improved diagnostics remain needs unmet in T2-low asthma

Biologic therapies show progress in severe asthma treatment and remission potential